Gonzalez, M., Long, G. V., Spillane, A. J., Saw, R. P., Menzies, A. M., Faries, M. B., Patel, S. P., Mandala, M., Massi, D., Barbour, A., Lai-Kwon, J. E., Law, C. K., Pennington, T. E., Ch'ng, S., Shannon, K. F., Rawson, R. V., Osorio, M., Rizos, H., Lo, S. N., Akkooi, A. C. J. V. (2026). A phase 3, international, multicenter, randomized, controlled trial of selective index lymph node resection versus therapeutic lymph node dissection after neoadjuvant immunotherapy for stage IIIB-D melanoma (MSLT-3/S2601/EORTC2519).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps9609